International Clinical Trial: A Study to Assess the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB161734 in Healthy Male Participants

Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (NCT07814404) titled 'A Study to Assess the Mass Balance, Pharmacokinetics, and Metabolite Profiles of a Single Oral Dose of [14C]-INCB161734 in Healthy Male Participants' on Sept. 4.

Study Type: Interventional

Study Design: Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: Incyte Corporation

Condition: Healthy Participants

Intervention: Drug: INCB161734

Recruitment Status: Not recruiting

Phase: Phase 1

Date of First Enrollment: September 18, 2026

Target Sample Size: 10

To know more, visit https://clinicaltrials.gov/study/NCT07814404

Publ...